Press Releases OncoNano Medicine Announces Pre-Clinical Data for Dual-Activating STING agonist at the Society for Immunotherapy of Cancer (SITC) Annual Meeting ONM-501 shown to be promising immuno-therapeutic candidate for clinical evaluation in solid tumors SOUTHLAKE, Texas…Oscar LazcanoNovember 14, 2022
Press Releases OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an adjunct to Cytoreductive Surgery of Peritoneal Carcinomatosis - Interim Phase 2 results presented at World Molecular Imaging Conference 2022 - - Pegsitacianine…Oscar LazcanoSeptember 29, 2022
Press Releases OncoNano Medicine to Present at Cantor Fitzgerald Oncology & HemOnc Conference SOUTHLAKE, Texas – September 19, 2022 – OncoNano Medicine, Inc., a clinical-stage biotechnology company focused…James KrahulaSeptember 19, 2022
Press Releases OncoNano Medicine Announces Oral Presentation of Phase 2 Study Data at the World Molecular Imaging Congress 2022 SOUTHLAKE, Texas – September 14, 2022 – OncoNano Medicine, Inc. today announced a presentation of…Oscar LazcanoSeptember 14, 2022
Press Releases OncoNano Medicine Appoints Kartik Krishnan, M.D., Ph.D., as Chief Medical Officer - Oncology Development Veteran to Lead the Advancement of OncoNano’s Portfolio SOUTHLAKE, Texas – June…James KrahulaJune 1, 2022
Press Releases OncoNano Medicine Announces the Appointment of Elina Lavit as Vice President, Business Development SOUTHLAKE, Texas – May 10, 2022 – OncoNano Medicine, Inc. today announced the appointment of…Oscar LazcanoMay 10, 2022
Daniel Murillo In Publications Digitization of endocytic pH by hybrid ultra-pH-sensitive nanoprobes at single-organelle resolution Visit: Digitization of endocytic pH by hybrid ultra-pH-sensitive nanoprobes at single-organelle resolution Read More
Daniel Murillo In Publications Molecular basis of cooperativity in pH-triggered supramolecular self-assembly Visit: Molecular basis of cooperativity in pH-triggered supramolecular self-assembly Read More